Pharma Business Week articles from June 2004

Pharma Business Week archives from June 2004

FDA issues not approvable letter for over-the-counter emergency contraceptive.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Barr Pharmaceuticals, Inc., (BRL) announced that it has received a Not Approvable Letter from the U.S. Food and Drug Administration (FDA) for the company's Supplemental New Drug Application (sNDA) for...

Cymbalta helped patients with depression stay better longer.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Patients treated successfully with 60 mg per day of the investigational antidepressant Cymbalta (duloxetine hydrochloride), were less likely to have their emotional and physical symptoms of depression...

Ambien shown to be safe, effective with longer-term use.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Results of a 12-week, placebo-controlled clinical trial with Ambien (zolpidem tartrate) C(IV) demonstrated that the product safely and effectively treated insomnia intermittently with no evidence of...

Special protocol assessment granted from FDA for trial of GVAX vaccine.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Cell Genesys, Inc., (CEGE) announced that it has received a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration (FDA) for its upcoming phase III clinical trial of GVAX prostate...

Licensee begins sales of "Ixora for Women".
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- LAM Pharmaceutical Corp. (LAMP), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced that Ixora Bio Medical Co.,...

Scientists discover how AIDS opens cell doors.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Researchers at the Salk Institute have discovered a way to view viruses like HIV upon cell entry. Published in the May 18 edition of the Proceedings of the National Academy of Sciences, this...

Data released on review of Amyloid clinical trial.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Axonyx, Inc., (AXYX) announced that the blinded data review that statistically reassessed the original variability estimate of the available data from the ongoing phase IIB Amyloid beta (A(B)) trial...

License extended for sale of monoclonal antibodies.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Senetek PLC (SNTK) announced an extension of its agreement with the research foundation under which Senetek is licensed to manufacture and sell monoclonal antibodies used to research various disease...

Protein found to dissolve amyloid fibers.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Research published in the May 21 online issue of Science shows a natural biological process by which yeast protein cells dismantle amyloid fibers, protein plaques found in the brains of patients with...

FDA approves LidoSite Topical System for local analgesia.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Vyteris, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Vyteris' New Drug Application (NDA) for its LidoSite Topical System. The system has been approved for use on...

Researchers identify compound in embryonic development that inhibits new blood vessel growth.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Researchers at the Weill Cornell Medical College have identified compounds in embryos that inhibit the growth of new blood vessels. Results of the animal studies have been published in the May 11 issue...

Anthim selected for testing by U.S. federal government.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Elusys Therapeutics, Inc., announced that its anti-anthrax antibody, trade name Anthim(ETI-204), was selected by the U.S. Centers for Disease Control and Prevention (CDC) for evaluation by the...

Encouraging antibiotic portfolio discussed at European meeting.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Bayer Pharmaceuticals Corporation continues to demonstrate its dedication to research and development in the anti-infective arena as evidenced by encouraging data presented at this year's European...

New compounds antifungal and anticancer but inactive against HIV-1 and bacteria.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- New alpha-(N)-heterocyclichydrazones have antifungal and anticancer properties but are inactive against HIV-1 and bacteria. According to recent research from Italy, "A series of 3- and...

Cisplatin-induced apoptosis associated with mitochondrial dysregulation.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Cisplatin-induced apoptosis is associated with mitochondrial dysregulation. "Human hepatoma cell lines undergo apoptosis after treatment with cisplatin (CP), by mechanisms that are not fully...

Top 10 reasons why arthritis sufferers should exercise.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Arthritis is becoming more and more common - and not just among the very old. The American Council on Exercise (ACE), America's non-profit fitness advocate, suggests 10 reasons for arthritis...

ADHD patients have more symptom improvement with Concerta vs. Strattera.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Children with attention deficit/hyperactivity disorder (ADHD) demonstrated greater improvement with symptoms such as hyperactivity, impulsivity, and attention with Concerta (methylphenidate HCl) CII...

Study patients show greater symptom improvement with Avodart vs. Proscar.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- New data presented at the annual meeting of the American Urological Association suggest that treatment with Avodart, the dual 5 alpha-reductase inhibitor (5ARI), may provide faster onset of symptom...

Early and aggressive treatment for high blood pressure may help treat hypertension.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Novartis Pharmaceuticals Corporation announced results of two studies of the drug Lotrel: one that treated African-Americans with diabetes, the other that treated elderly patients with high blood...

FDA approves drug for bone marrow disease.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration has announced approval of Pharmion Corporation's Vidaza (azacitidine) injection, the first effective treatment for Myelodysplastic Syndrome (MDS). MDS refers...

Novel stimulators of osteoprotegerin expression inhibit bone resorption.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Novel and selective small molecule stimulators of osteoprotegerin expression inhibit bone resorption. According to recent research published in the Journal of Pharmacology and Experimental...

DoD awards $10M grant for breast cancer research.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Insmed, Inc., (INSM) announced that the U.S. Department of Defense has granted a group of leading oncologists $10 million to support therapeutic individualization for breast cancer treatment in a...

FDA accepts NDA for Abraxane for treatment of metastatic breast cancer.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APP) (APPX) and American BioScience, Inc., (ABI) announced that the New Drug Application (NDA) for Abraxane has been accepted for filing with standard review by...

Male breast cancer on the increase, but remains rare.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Male breast cancer represents less than 1% of all male cancers, but a recent study by Dr. Sharon H. Giordano of the University of Texas M.D. Anderson Cancer Center has found male breast cancer on the...

New study may link aspirin use to reduced risk of breast cancer.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- According to a study published in the May 26 issue of The Journal of the American Medical Association, women who use aspirin regularly appear to have reduced risk of breast cancer. In an effort to...

Drug delivery company completes strategic reorganization.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Antares Pharma, Inc., (ANTR) announced it has completed its strategic reorganization that began in early 2003 with the outsourcing of production and assembly operations. Throughout 2003 and early...

Drug development strategic alliance consummated and funded.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Theravance, Inc., announced that the strategic alliance with GlaxoSmithKline (GSK), previously announced on March 31, was consummated and funded after receiving the requisite regulatory and Theravance...

Oncology company reports on finances, drug R&D pipeline progress.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- CancerVax Corporation (CNVX) announced financial results for the first quarter of 2004 and provided an update on the company's drug development pipeline. For the 3 months ended March 31, 2004, the...

Oncology company reports record product revenues.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Cytogen Corporation (CYTO) reported its consolidated financial results for the first quarter ended March 31, 2004. Total revenues for the first quarter of 2004 were $3.6 million compared to $2.5...

Women's healthcare drug maker reports loss of $0.16 per share.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Columbia Laboratories, Inc., (CBRX) announced financial results for the first quarter ended March 31, 2004. For the first quarter of 2004, the company reported a loss of $6,254,829, or $0.16 per...

AmericsourceBergen Corp. looks to aging America for growth.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Getting older? Pennsylvania's top Fortune 500 company is counting on it. That is one trend AmerisourceBergen Corp., the third-largest U.S. drug wholesaler, says will get its profits back to...

Company adds 22 products to line for consumers and the medical industry.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- HealthRenu Medical (HRUM) has expanded their product line by adding another 22 products, surpassing company expectations. In addition, HealthRenu Medical is expecting to release two more products...

Indian and U.S. drug companies enter marketing, distribution alliance.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Spectrum Pharmaceuticals, Inc., (SPPI) has entered into a marketing and distribution alliance with Shantha Biotechnics Pvt. Ltd. Spectrum will be responsible for all regulatory, marketing, and...

Multiferon shelf life extended, new marketing campaign initiated.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Viragen, Inc., (VRA) announced that the Swedish Medical Products Agency (MPA) has approved extending the shelf life of Multiferon to 18 months from its previously approved labeling of 12 months. ...

Pharmion up as drug seen nearing FDA approval.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Pharmion Corp. stock hit a new high May 19, 2004, after one Wall Street firm said the company expects approval of one of its major drug candidates. Pharmion's stock hit $30.74, above the prior high...

Protein therapeutics technology company acquired.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Centocor, a biomedical company involved in treatments for immune disorders and infectious diseases, announced that its parent company, Johnson & Johnson, acquired Egea Biosciences, Inc., a...

FDA approves new treatment for prostate cancer.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration has approved the Aventis drug Taxotere with prednisone for treatment in men with androgen-independent metastatic prostate cancer. Taxotere is a drug in the...

New guide compiles information on colorectal cancer research.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Research and Markets, a research reports organization, has announced a new compendium of information on colorectal cancer. Entitled, Analysis of Colorectal Cancer R&D - the Complete Guide, the...

Scientists link gene family mutation to colon cancer.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Research published in the May 21 issue of Science shows mutations in a family of genes linked to more than a quarter of colon cancers, as well as other cancers. Scientists from the Johns Hopkins...

Antitumor activity of a kinesin spindle protein demonstrated.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Cytokinetics, Inc., (CYTK) announced the publication of detailed preclinical research findings from a study demonstrating the feasibility of small molecule inhibition of kinesin spindle protein (KSP)...

Collaborators to develop novel form of immune-enhancing drug for cancer.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Viragen, Inc., (VRA) announced that the company extended its agreement with the University of Miami and UM/Sylvester Comprehensive Cancer Center to develop a novel form of an immune-enhancing drug (IEP...

Study shows less than half of heart attack survivors take regular beta-blocker therapy.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- According to a study conducted by the Council for Affordable Quality Healthcare, less than half of heart attack survivors continue taking beta-blocker during the first year after the attack. In a...

Larynx cells may play role in immune system.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The head of a U.K. laryngeal research group, speaking at the Laryngopharyngeal Reflux, Dysphagia, and Laryngology conference held at Wake Forest University, said that cells lining the larynx have...

Living cells able to destroy chemical messages to halt certain protein production.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Scientists at the Ohio State University Comprehensive Cancer Center have found that living cells may destroy the chemical messages that contain information for making proteins, sometimes as they are...

Collaboration to focus on GPCR and ion channel technologies.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Bionomics Limited and PerkinElmer, Inc., (PKI) announced that they have reached an agreement to collaborate on GPCR and Ion Channel Technologies. This collaboration recognizes the value of...

Investigator site training boosts patient recruitment, study shows.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Clinical trial executives rank ongoing training of investigator site personnel as the most effective tool for boosting patient recruitment, according to a new report from pharmaceutical business...

Product development partnership to offer clinical trials management solutions.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Perceptive Informatics, Inc., and Acurian, Inc., have expanded their strategic product development partnership. Perceptive Informatics will integrate Acurian's investigator database and aggregate...

Antibody discovery collaboration formed for autoimmune, inflammatory disorders.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Syntonix Pharmaceuticals, Inc., announced that the company has entered into a collaboration with Dyax Corp. (DYAX) for the discovery and development of therapeutic antibodies to treat autoimmune and...

Bioterror vaccine maker partners with biotech company for $2M deal.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Covalent Group, Inc., (CVGR) announced that it has been awarded a new multi-study clinical research program with a top-tier biopharmaceutical company. The initial contract within this program is for...

Deal signed to develop fusion proteins.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Avidex and Active Biotech have formed a collaboration to create targeted immunotherapeutics for cancer by bringing together the two companies' most powerful protein molecule platforms. Under the...

Deal signed to market Genpharm's generic Paxil.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Andrx Corporation (ADRX) announced that it has entered into an agreement with Genpharm, Inc., to obtain exclusive U.S. marketing rights for bioequivalent versions of Paxil (paroxetine) 10mg, 20mg, 30mg...

Genomics firm launches kinase sequencing assays.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Agencourt Bioscience Corporation, a provider of genomic services and nucleic acid purification products to the life sciences industry, announced the launch of an expanded SNP discovery service for...

Juvaris collaborates with RNA-based gene-inhibition technology company.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Juvaris BioTherapeutics, Inc., and SomaGenics, Inc., both private biotechnology companies, announced that they have entered into a collaboration to develop products combining their technologies. ...

New approach to cell-based drug discovery acquired from Amphora Discovery.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Caliper Life Sciences, Inc., (CALP) and Amphora Discovery Corp. announced that they have entered into a definitive agreement for Caliper to acquire certain technology developed by Amphora for cell-based...

Platform licensed for treatment of neurological disorders.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- BioLineRx, Ltd., announced that it has signed an in-license agreement covering the development of novel compounds for the treatment of neurological disorders including schizophrenia, neurodegenerative...

Second oral drug delivery research deal signed.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc., (AKC) announced that it has commenced a second oral drug delivery research collaboration with a major pharmaceutical company. This new research collaboration is aimed...

New study shows African-Americans more likely to die of colon cancer.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- According to a new study published in the May 24 online edition of Cancer, African-Americans with colon cancer are more 50% likely to die from their cancer within 5 and 10 years after surgery than...

Uncaria tomentosa extracts have potential application as immunomodulator.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Uncaria tomentosa extracts have a potential application as immunomodulators. "In the traditional Peruvian medicine, hot aqueous extracts of Uncaria tomentosa have been used for the treatment of a...

Positive results reported in study of constipation drug.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Sucampo Pharmaceuticals, Inc., announced that the active treatment period of its randomized withdrawal (RW) study for treating constipation with its proprietary agent SPI-0211 has duplicated the...

First full month of U.S. Taxus sales reported.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced preliminary information related to U.S. sales of its Taxus Express2 paclitaxel-eluting coronary stent systems for the month of April. Preliminary net...

FDA approves Mucinex DM extended-release tablets.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Adams Respiratory Therapeutics, a provider of specialty pharmaceuticals for respiratory care, announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Mucinex DM in...

Depressed patients showed improvement with Lexapro.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Forest Laboratories, Inc., (FRX) announced the results of a clinical study, which found that Lexapro (escitalopram oxalate) is a beneficial and well-tolerated treatment for depressed patients who failed...

Results of Corcept clinical study presented at psychiatry conference.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Corcept Therapeutics Incorporated (CORT) announced that Joseph Belanoff, Corcept's chief executive officer, presented the results of the Corcept '03 clinical study investigating the use of its lead...

Long-term research study shows link between diabetes and risk of Alzheimer's disease.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The results of a new study supported by the National Institute on Aging (NIA) and published in the May issue of the Archives of Neurology showed that diabetes mellitus was linked to a 65% increased risk...

First shipment of Sucanon diabetes drug made to Mexico.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Robert Rieveley, president of Biotech Holdings (BIO.V; BIOHF), announced the first shipment of the company's Sucanon diabetes drug. "We are pleased to report that the first shipment of Sucanon...

Consumer advocate renews call for ban on cholesterol drug.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- A consumer advocate is urging the government to ban the new anti-cholesterol drug Crestor, citing new cases of a life-threatening muscle side effect among patients taking a low dose thought to minimize...

Results of tablet-splitting study available.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- According to a study of patients using cyclobenzapring HCl, a frequently prescribed muscle relaxant, those patients that split their own doses may receive anywhere from 50 to 150 percent of what they...

37% of pharmaceutical R&D budgets spent on clinical affairs, study shows.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Drug companies spend an average 37% of their overall research and development budgets on clinical affairs, according to Cutting Edge Information's report, "Accelerating Clinical Trials: Budgets, Patient...

New factor Xa inhibitors synthesized.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Scientists have synthesized a series of factor Xa inhibitors containing a spiro[5H-oxazolo[3,2-a] pyrazine-2(3H),4'-piperidin]-5-one skeleton. According to published research from Japan, "In the...

Strategic alliance to develop diabetes and cancer drug candidates.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Roche and Syrrx announced a strategic partnership focused on the discovery and development of drug candidates to treat cancer and type 2 diabetes. The preclinical programs focus on two emerging...

New report evaluates drug leads.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Research and Markets, a research reports organization, has announced the availability of a new report that looks at how the pharmaceutical industry evaluates new drug leads. Entitled, Advance in...

Use of Viagra plus certain alpha blockers doesn't induce cardio side effects.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- In men being treated with an alpha-blocker for benign prostatic hyperplasia (BPH) while also receiving sildenafil citrate for erectile dysfunction, those receiving Flomax (tamsulosin hydrochloride) and...

Integrated system launched to improve gene expression analyses for whole blood.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Applied Biosystems (ABI), an Applera Corporation, announced the introduction of the Tempus Blood RNA Tubes, an evacuated blood collection tube containing a reagent that stabilizes large quantities of...

American Stock Exchange lists common stock of drug delivery firm.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- The American Stock Exchange (Amex) listed the common stock of NovaDel Pharma, Inc., under the ticker symbol NVD. NovaDel Pharma, Inc., is a drug delivery company engaged in the development of novel...

Bioactive products developer announces first quarter financial results.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Protein Polymer Technologies, Inc., (PPTI) announced financial results for the first quarter ended March 31, 2004. The net loss applicable to common shareholders for the quarter ended March 31,...

Biopharmaceutical company announces financial results for first quarter 2004.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Progenics Pharmaceuticals, Inc., (PGNX) announced its results of operations for the quarter ended March 31, 2004. Revenues for the quarter ended March 31, 2004, totaled $1.7 million compared to...

Biopharmaceutical company announces quarterly financial results.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Tanox, Inc., (TNOX) announced quarterly financial results for the quarter ended March 31, 2004. Revenues for the 3 months ended March 31, 2004, were $9.0 million compared to $5,000 for the same...

Biopharmaceutical company reports first quarter 2004 financial results.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Point Therapeutics, Inc., (POTP) reported financial results for the fiscal quarter ended March 31, 2004. Point reported a net loss of $3,135,000 or $0.21 per share, in the first quarter of 2004,...

Biopharmaceutical company reports loss of $136.4M.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Cell Therapeutics, Inc., (CTI, CTIC) reported financial results for the quarter ended March 31, 2004. Total revenues for the quarter were $4.5 million compared to $4.9 million in the first quarter...

Biopharmaceutical company reports net loss in first quarter 2004.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Xoma Ltd. (Xoma) announced results for the quarter ended March 31, 2004. For the first quarter of 2004, the company recorded a net loss of $20.2 million or $0.24 per share compared with $13.1...

Biopharmaceutical company reports third quarter financial results.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Palatin Technologies, Inc., (PTN) announced results for its third quarter ended March 31, 2004. Palatin reported revenues for the third quarter of fiscal year 2004 of $180,754, with a net loss of...

Biotech company announces private offering of senior subordinated notes.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- CV Therapeutics, Inc., (CVTX) announced that it has agreed to sell $125.0 million aggregate principal amount of its 2.75% senior subordinated convertible notes due 2012 through a private placement to...

Biotech company reports earnings of $0.37 per share.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- Cephalon, Inc., (CEPH) reported first quarter 2004 revenue of $215.0 million and diluted earnings per share of $0.37, which includes a $4.2 million pre-tax gain associated with benefits changes at...

Biotech company reports loss of $0.09 per share.
June 7, 2004... 2004 JUN 7 - (NewsRx.com & NewsRx.net) -- CytRx Corporation (CYTRE) announced the results of its operations for the fourth quarter and fiscal year ended December 31, 2003. The company has also now filed its annual report on Form 10-K for...